Which States Let Nurse Practitioners Prescribe Ketamine via Telemedicine?

Nurse Practitioners and Ketamine Prescribing

Nurse practitioners (NPs) play an increasingly prominent role in telehealth ketamine therapy. Many of the major online ketamine platforms employ NPs alongside physicians as prescribers. For patients, a natural question arises: which states let nurse practitioners prescribe ketamine via telemedicine, and are there restrictions that affect the quality or legality of my care?

The answer is nuanced because NP prescribing authority is governed by a complex interaction of state nursing board regulations, state medical board rules, DEA federal requirements, and telehealth-specific laws. This article breaks down the key factors.

Understanding NP Practice Authority Levels

The American Association of Nurse Practitioners (AANP) categorizes state NP practice environments into three levels. These categories fundamentally shape whether and how an NP can prescribe ketamine.

Full Practice Authority (FPA) States

In full practice authority states, NPs can evaluate patients, diagnose conditions, and prescribe medications — including Schedule III controlled substances like ketamine — without physician oversight or a collaborative agreement. The NP operates independently within their scope of practice.

As of 2025, approximately 27 states plus the District of Columbia grant full practice authority to nurse practitioners. These include:

Arizona, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Maine, Maryland, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oregon, Rhode Island, South Dakota, Utah, Vermont, Washington, Wyoming, Alaska, and the District of Columbia, among others. Several states have transitioned to FPA in recent years, and the list continues to grow.

In these states, an NP with a valid state nursing license and DEA registration can independently prescribe ketamine via telemedicine, provided they comply with all applicable telehealth laws.

Reduced Practice States

Reduced practice states allow NPs to engage in at least one element of practice (evaluation, diagnosis, or prescribing) only under a collaborative agreement or supervision arrangement with a physician. The specific requirements vary:

• Some states require a formal written collaborative agreement with a named physician
• Some require the collaborating physician to review a percentage of charts
• Some limit the controlled substance schedules an NP can prescribe under collaboration

In these states, an NP can typically prescribe ketamine via telemedicine as long as the collaborative agreement is in place and the agreement specifically covers controlled substance prescribing. The collaborating physician does not need to be present during the telemedicine visit, but they must be available and must review cases according to the state's requirements.

States in this category include Alabama, Illinois, Indiana, Kansas, Mississippi, Missouri, New Jersey, Ohio, Pennsylvania, South Carolina, Virginia, Wisconsin, and others.

Restricted Practice States

Restricted practice states require physician supervision for NP prescribing. In some of these states, NPs may have limited or no authority to prescribe Schedule III controlled substances independently.

States with the most restrictive NP practice environments include California (which has been transitioning), Georgia, Oklahoma, Tennessee, and Texas. However, it is important to note that "restricted" does not necessarily mean NPs cannot prescribe ketamine at all — it means they require a higher level of physician involvement.

In Texas, for example, NPs must have a prescriptive authority agreement with a delegating physician, and there are specific requirements around controlled substance prescribing that include site-based provisions that can complicate telemedicine arrangements.

Federal Requirements That Apply Everywhere

Regardless of state practice authority level, several federal requirements apply to every NP prescribing ketamine via telemedicine.

DEA Registration

Every NP who prescribes ketamine must hold their own DEA registration. This is a federal requirement that applies in all 50 states. The DEA registration authorizes the prescriber to handle controlled substances and assigns a unique DEA number that pharmacies verify before dispensing.

NPs apply for DEA registration through the DEA Diversion Control Division. The registration must be maintained with biennial renewal and is tied to a specific state — NPs practicing in multiple states need registrations in each state.

The Ryan Haight Act

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 establishes that a valid prescription for a controlled substance issued via telemedicine generally requires at least one in-person evaluation or must meet one of the Act's specific exceptions. During the COVID-19 public health emergency, the DEA issued temporary flexibilities allowing initial telemedicine prescribing of controlled substances without an in-person visit.

The DEA has been developing permanent telemedicine prescribing rules. As of early 2025, the DEA proposed frameworks that would allow initial telemedicine prescribing of Schedule III-V controlled substances (including ketamine) under certain conditions, such as the use of audio-visual telemedicine (not audio-only) and quantity limits on initial prescriptions.

These federal rules apply to all prescribers — physicians and NPs alike. Check the DEA's current telemedicine regulations before initiating treatment, as this area of law is actively evolving. Our DEA compliance guide covers these requirements in detail.

State Telemedicine Laws

Most states have enacted telemedicine-specific laws that govern how prescribers — including NPs — can practice via telehealth. These laws may impose requirements beyond what the DEA mandates, including:

• Standard of care requirements: The care provided via telemedicine must meet the same standard as in-person care
• Prescriber-patient relationship establishment: Some states specify what constitutes a valid prescriber-patient relationship for telemedicine
• Technology requirements: Some states require audio-visual (video) consultations rather than audio-only for controlled substance prescribing
• State licensure: The prescriber must be licensed in the state where the patient is located at the time of the consultation

State-by-State Considerations

Rather than listing all 50 states — which would quickly become outdated as laws change — here are the key questions to ask about your specific state:

Questions to Research for Your State

1. Does your state grant NPs full, reduced, or restricted practice authority? Check the AANP's state practice environment map at aanp.org for current classifications.
2. Can NPs in your state prescribe Schedule III controlled substances? Most states permit this, but some impose specific limitations on which schedules NPs can prescribe.
3. Does your state require a collaborative agreement for NP controlled substance prescribing? If so, ask your telehealth provider to confirm that such an agreement is in place.
4. Does your state impose special telemedicine requirements for controlled substances? Some states require an initial in-person visit before telemedicine prescribing of controlled substances, while others have adopted more flexible rules.
5. Is the NP licensed in your state? The NP must hold an active license in the state where you are physically located during the consultation. Multi-state compact licenses (through the APRN Compact) can simplify this, but the compact has limited adoption so far.

How This Affects Your Telehealth Ketamine Experience

Understanding NP prescribing authority matters practically for several reasons.

Legitimacy Verification

If your telehealth ketamine provider employs NPs as prescribers, knowing your state's rules helps you verify that the arrangement is legal. In a full practice authority state, an NP prescribing ketamine independently is operating within the law. In a restricted practice state, you can ask whether a collaborating physician is involved in your care.

Quality of Care

The clinical evidence does not support the idea that NPs provide inferior ketamine prescribing compared to physicians. NPs undergo extensive training in pharmacology, assessment, and prescribing. A study published in Medical Care found no significant difference in patient outcomes between NP-led and physician-led primary care, and this extends to specialty prescribing when NPs have appropriate training and experience.

What matters more than the credential letters after your prescriber's name is their specific experience with ketamine therapy, their thoroughness in evaluation and monitoring, and the overall safety protocols of the program.

Collaborative Models Can Be Advantageous

In states requiring physician collaboration, the collaborative agreement means that a physician is reviewing cases and available for consultation. This additional layer of oversight can actually be a safety advantage — particularly for complex patients with multiple comorbidities or medication interactions.

Some telehealth ketamine providers voluntarily implement physician oversight models even in full practice authority states, recognizing that the additional clinical review improves safety.

The APRN Compact

The APRN Compact — modeled on the Nurse Licensure Compact (NLC) — would allow NPs to practice across state lines with a single multistate license. As of 2025, the APRN Compact has been enacted in a limited number of states and is not yet operational in most of the country.

When fully implemented, the APRN Compact will significantly simplify interstate telemedicine prescribing by NPs, reducing the administrative burden of maintaining separate licenses in each state. For patients, this means potentially greater access to NP-led telehealth ketamine services, particularly in underserved areas.

Until the compact is widely adopted, NPs must hold individual licenses in each state where their patients are located. This is why some telehealth ketamine providers are available in 30-35 states rather than all 50 — their prescribers are not licensed everywhere.

States to Watch

Several states have recently changed or are actively considering changes to NP practice authority:

• California transitioned to a form of expanded practice authority under AB 890 (2020), with full implementation rolling out in phases. The law allows NPs with additional training and experience to practice without standardized procedures after a transition period.
• New York has periodically considered full practice authority legislation, though it has not yet passed.
• Florida expanded NP prescribing authority in recent years, though with some limitations on controlled substances.
• Texas continues to have one of the more restrictive environments but faces ongoing legislative pressure to expand NP authority.

Practical Advice for Patients

If you are considering telehealth ketamine therapy and want to ensure your provider is operating legally with respect to NP prescribing:

1. Ask who will evaluate and prescribe. A legitimate provider will tell you whether your prescriber is a physician, NP, or PA.
2. If an NP, ask about their prescribing authority arrangement. In reduced or restricted practice states, ask whether a collaborative agreement with a physician is in place.
3. Verify the NP's license. Your state board of nursing maintains a public license lookup. Confirm the NP's license is active, unrestricted, and in good standing.
4. Confirm DEA registration. While DEA registrations are not publicly searchable by individuals, the dispensing pharmacy will verify this. You can also ask the provider to confirm their prescriber holds a valid DEA registration.
5. Do not assume all states are the same. A provider operating legally in one state may not be compliant in another. If you move or travel, confirm that your provider can legally serve you in your new location.

The Bigger Picture

The question of which states let nurse practitioners prescribe ketamine via telemedicine is ultimately a question about access. In states with full practice authority, NPs expand the pool of available prescribers, making telehealth ketamine more accessible to more patients. In restricted states, the requirement for physician involvement can create bottlenecks that limit access — particularly in rural and underserved areas where physicians are scarce.

The trend in healthcare regulation is toward expanded NP practice authority. The evidence supports NP safety and effectiveness, and the access needs of patients — particularly in mental health — continue to outpace the available physician workforce. For telehealth ketamine therapy, this trend means that NP-led care will likely become even more common and more widely accepted in the coming years.

References

• American Association of Nurse Practitioners — State Practice Environment — Current state-by-state NP practice authority classifications
• DEA — Telemedicine Prescribing Rules — Federal framework for telemedicine prescribing of controlled substances
• Ryan Haight Online Pharmacy Consumer Protection Act — Federal law governing online controlled substance prescribing
• Stanik-Hutt J, et al. (2013). The Quality and Effectiveness of Care Provided by Nurse Practitioners. Journal for Nurse Practitioners, 9(8), 492-500 — Evidence on NP quality of care outcomes
• National Council of State Boards of Nursing — APRN Compact — Information on multistate NP licensing
• NIH — Expanding Access to Mental Health Treatment — Federal resources on mental health treatment access